[人表皮生长因子受体2阳性乳腺癌的诊断与治疗：中国抗癌协会专家共识] - Suppr

[Diagnosis and treatment of HER-2-positive breast cancer: Expert consensus of the Chinese Anti-Cancer Association].

作者信息

Jiang Ze-Fei, Shao Zhi-Min, Xu Bing-He

出版信息

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):158-60.

PMID:20403251

Abstract

摘要

相似文献

[Diagnosis and treatment of HER-2-positive breast cancer: Expert consensus of the Chinese Anti-Cancer Association].

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):158-60.

Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancer.

Oncologist. 2006 May;11(5):533; author reply 534. doi: 10.1634/theoncologist.11-5-533.

Trastuzumab plus chemotherapy improves survival in early-stage HER2-positive breast cancer patients.

Oncology (Williston Park). 2005 Jun;19(7):851, 862.

Why adjuvant trastuzumab led to better outcomes in women with high-risk HER-2-positive breast cancer.

Breast J. 2006 Sep-Oct;12(5):497-8. doi: 10.1111/j.1075-122X.2006.00314.x.

Herceptin (trastuzumab): adjuvant and neoadjuvant trials.

Isr Med Assoc J. 2006 Jun;8(6):416-21.

High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer.

Acta Oncol. 2008;47(8):1564-9. doi: 10.1080/02841860802060844.

Neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for HER-2-positive operable breast cancer.

J Clin Oncol. 2005 Oct 20;23(30):7759-60; author reply 7760-1. doi: 10.1200/JCO.2005.03.0213.

Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.

J Clin Oncol. 2007 Dec 10;25(35):5667-9. doi: 10.1200/JCO.2007.14.6134.

[Advances in herceptin neoadjuvant therapy and adjuvant therapy of breast cancer].

Zhonghua Zhong Liu Za Zhi. 2006 Apr;28(4):241-3.

The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.

J Clin Oncol. 2008 Mar 10;26(8):1216-22. doi: 10.1200/JCO.2007.12.0733.

引用本文的文献

[Expression of G9a in breast cancer and its effect on proliferation of breast cancer cells ].

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Apr 30;39(4):477-484. doi: 10.12122/j.issn.1673-4254.2019.04.15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Diagnosis and treatment of HER-2-positive breast cancer: Expert consensus of the Chinese Anti-Cancer Association].

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献